← Eichor
Condition: Oral Cancer Oral Squamous Cell Carcinoma Oral Cavity Cancer Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Oral Cancer Oral Squamous Cell Carcinoma Oral Cavity Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Proactive Risk-based Optimization & Notifications for Treatment & Outcomes in Head & Neck Cancer
NA · 1 location(s) · Centre hospitalier de l'Université de Montréal (CHUM) · NCT07180901Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patient
Phase 2 · 153 location(s) · NRG Oncology · NCT06532279Sentinel Node Biopsy Versus Limited Elective Neck Dissection in Early Cancers of Oral Cavity NoDe Negative
NA · 3 location(s) · Tata Memorial Hospital · NCT05774483A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Ca
Phase 3 · 205 location(s) · Merus B.V. · NCT06525220Rice Bran Supplementation for Radiation-Induced Oral Mucositis in Head and Neck Cancer
NA · 1 location(s) · Christina Milad Lobos · NCT07242859Detection of Oral and Throat Cancers Using OralViome Cancer Testing System
Phase N/A · 1 location(s) · Viome · NCT05451303BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or S
Phase 2 · 225 location(s) · National Cancer Institute (NCI) · NCT05136196Antibiotic Treatment Effects on Intratumoral Bacteria Modulation in Surgical Patients With Oral Cancer
Phase 2 · 1 location(s) · Case Comprehensive Cancer Center · NCT06627270Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-esca
Phase 2 · 1 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT07209189Cemiplimab and Cetuximab Prior Salvage Surgery in Patients With Recurrent Oral Cavity and HPV-negative Oropharyngeal Squ
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT06448026Study of TU2218 in Combination With KEYTRUDA®(Pembrolizumab) in Patients With Advanced Solid Tumors
Phase 1/Phase 2 · 11 location(s) · TiumBio Co., Ltd. · NCT05784688Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
Phase 1 · 18 location(s) · National Cancer Institute (NCI) · NCT05172245Fluorescence-guided Surgery Using cRGD-ZW800-1 in Oral Cancer
Phase 2 · 1 location(s) · Erasmus Medical Center · NCT04191460Compartmentalized Postoperative Radiotherapy in Head and Neck Cancer
Phase 2 · 3 location(s) · Olgun Elicin · NCT07058805Cyclin D1 Based TPF Induction Chemotherapy for Oral Squamous Cell Carcinoma Patients at Clinical N2 Stage
Phase 2 · 1 location(s) · Shanghai Jiao Tong University School of Medicine · NCT02290145Tolerance and Benefits of Mandibular Advanced Device for Snoring and Sleep Apnea in Oropharyngeal Cancer.
NA · 1 location(s) · Centre hospitalier de l'Université de Montréal (CHUM) · NCT05719779A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
Phase 1/Phase 2 · 14 location(s) · Volastra Therapeutics, Inc. · NCT05902988Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy
NA · 4 location(s) · Medical University of South Carolina · NCT05793151Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia.
NA · 1 location(s) · Alpha Tau Medical LTD. · NCT038898994 Courses vs 2 Courses of Pembrolizumab Combined With Carboplatin and Albumin-binding Paclitaxel of Neoadjuvant Therapy
Phase 2 · 1 location(s) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · NCT05980702High-Resolution PET-CT Imaging for Surgical Margin Visualization
NA · 1 location(s) · Vanderbilt-Ingram Cancer Center · NCT06915454Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
Phase 2 · 100 location(s) · National Cancer Institute (NCI) · NCT07195734Surgeon-performed Ultrasound for Real-time Guidance In Oral Cancer Surgeries - A Multicenter Randomized Controlled Trial
NA · 7 location(s) · Tobias Todsen · NCT07203911"Ultra-High Frequency intraOral UltraSonography of the TONgue" (HOUSTON)
NA · 1 location(s) · University of Pisa · NCT06336941Defining TRPV4 Contribution of Schwann Cells to Oral Cancer Pain
NA · 1 location(s) · New York University · NCT07095608Reflectance Confocal Microscopy of Oral Cancers in Vivo: a Preliminary Trial Comparing Intra-oral Imaging With Pathology
Phase N/A · 5 location(s) · Memorial Sloan Kettering Cancer Center · NCT02507141Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer
Phase 1 · 1 location(s) · VLP Therapeutics · NCT06736379Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Can
Phase N/A · 1 location(s) · University of Colorado, Denver · NCT00900419Personalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsy for the Treatment of Oral Cavity Squamous Cel
Phase 2 · 1 location(s) · University of Michigan Rogel Cancer Center · NCT07121595SYsteMatical Trained learnIng aLgorithms for Oral carcInogenesiS Interpretation by Optical Coherence Tomography
Phase N/A · 1 location(s) · University of Palermo · NCT06321003
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.